A citation-based method for searching scientific literature

Christo Kole, Nikolaos Charalampakis, Sergios Tsakatikas, Maximos Frountzas, Konstantinos Apostolou, Dimitrios Schizas. Cancer Manag Res 2022
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Pembrolizumab As Second-Line Therapy in Patients With Advanced Hepatocellular Carcinoma in KEYNOTE-240: A Randomized, Double-Blind, Phase III Trial.
Richard S Finn, Baek-Yeol Ryoo, Philippe Merle, Masatoshi Kudo, Mohamed Bouattour, Ho Yeong Lim, Valeriy Breder, Julien Edeline, Yee Chao, Sadahisa Ogasawara,[...]. J Clin Oncol 2020
599
100

Molecular classifications of gastric cancers: Novel insights and possible future applications.
Silvio Ken Garattini, Debora Basile, Monica Cattaneo, Valentina Fanotto, Elena Ongaro, Marta Bonotto, Francesca V Negri, Rosa Berenato, Paola Ermacora, Giovanni Gerardo Cardellino,[...]. World J Gastrointest Oncol 2017
37
100

Tumor-stromal crosstalk in pancreatic cancer and tissue fibrosis.
Divya Thomas, Prakash Radhakrishnan. Mol Cancer 2019
137
100

PD-L1 and gastric cancer prognosis: A systematic review and meta-analysis.
Lihu Gu, Manman Chen, Dongyu Guo, Hepan Zhu, Wenchao Zhang, Junhai Pan, Xin Zhong, Xinlong Li, Haoran Qian, Xianfa Wang. PLoS One 2017
122
100


Targeting the Tumor Stroma: the Biology and Clinical Development of Pegylated Recombinant Human Hyaluronidase (PEGPH20).
Kit Man Wong, Kathryn J Horton, Andrew L Coveler, Sunil R Hingorani, William P Harris. Curr Oncol Rep 2017
74
100

The Role of Tumor Microenvironment in Cancer Immunotherapy.
Timothy Frankel, Mirna Perusina Lanfranca, Weiping Zou. Adv Exp Med Biol 2017
65
100

MHC independent anti-tumor immune responses induced by Hsp70-enriched exosomes generate tumor regression in murine models.
Jung-ah Cho, Yeong-Shin Lee, Soo-Hyun Kim, Jin-Kyung Ko, Chul-Woo Kim. Cancer Lett 2009
96
100

The Resistance Mechanisms of Checkpoint Inhibitors in Solid Tumors.
Evangelos Koustas, Panagiotis Sarantis, Athanasios G Papavassiliou, Michalis V Karamouzis. Biomolecules 2020
15
100

Phase I/II study of S-1 plus cisplatin combined with peptide vaccines for human vascular endothelial growth factor receptor 1 and 2 in patients with advanced gastric cancer.
Toru Masuzawa, Yoshiyuki Fujiwara, Kaoru Okada, Ayumu Nakamura, Shuji Takiguchi, Kiyokazu Nakajima, Hiroshi Miyata, Makoto Yamasaki, Yukinori Kurokawa, Ryuji Osawa,[...]. Int J Oncol 2012
52
100

Oncolytic vaccinia virus for the treatment of cancer.
Kilian Guse, Vincenzo Cerullo, Akseli Hemminki. Expert Opin Biol Ther 2011
55
100

Sequential therapy with JX-594, a targeted oncolytic poxvirus, followed by sorafenib in hepatocellular carcinoma: preclinical and clinical demonstration of combination efficacy.
Jeong Heo, Caroline J Breitbach, Anne Moon, Chang Won Kim, Rick Patt, Mi Kyung Kim, Yu Kyung Lee, Sung Yong Oh, Hyun Young Woo, Kelley Parato,[...]. Mol Ther 2011
91
100

Neoadjuvant treatment strategies for intrahepatic cholangiocarcinoma.
Clifford Akateh, Aslam M Ejaz, Timothy Michael Pawlik, Jordan M Cloyd. World J Hepatol 2020
21
100

Clinical and immune responses to anti-CD3 x anti-EGFR bispecific antibody armed activated T cells (EGFR BATs) in pancreatic cancer patients.
Lawrence G Lum, Archana Thakur, Minsig Choi, Abhinav Deol, Vidya Kondadasula, Dana Schalk, Kristie Fields, Melissa Dufrense, Philip Philip, Gregory Dyson,[...]. Oncoimmunology 2020
16
100


Colorectal cancer vaccines: Tumor-associated antigens vs neoantigens.
Sandra Wagner, Christina S Mullins, Michael Linnebacher. World J Gastroenterol 2018
44
100

Myeloid-Derived Suppressor Cells in Colorectal Cancer.
Izabela Sieminska, Jarek Baran. Front Immunol 2020
18
100

BRAF mutations, microsatellite instability status and cyclin D1 expression predict metastatic colorectal patients' outcome.
Z Saridaki, D Papadatos-Pastos, M Tzardi, D Mavroudis, E Bairaktari, H Arvanity, E Stathopoulos, V Georgoulias, J Souglakos. Br J Cancer 2010
78
100

Correction: Macrophage-derived CCL5 facilitates immune escape of colorectal cancer cells via the p65/STAT3-CSN5-PD-L1 pathway.
Chao Liu, Zhaoying Yao, Jianing Wang, Wen Zhang, Yan Yang, Yan Zhang, Xinliang Qu, Yubing Zhu, Jianjun Zou, Sishi Peng,[...]. Cell Death Differ 2020
1
100


A Phase II Study of Allogeneic GM-CSF-Transfected Pancreatic Tumor Vaccine (GVAX) with Ipilimumab as Maintenance Treatment for Metastatic Pancreatic Cancer.
Annie A Wu, Katherine M Bever, Won Jin Ho, Elana J Fertig, Nan Niu, Lei Zheng, Rose M Parkinson, Jennifer N Durham, Beth Onners, Anna K Ferguson,[...]. Clin Cancer Res 2020
30
100

Role of autophagy in cholangiocarcinoma: An autophagy-based treatment strategy.
Evangelos Koustas, Eleni-Myrto Trifylli, Panagiotis Sarantis, Athanasios G Papavassiliou, Michalis V Karamouzis. World J Gastrointest Oncol 2021
3
100

Antigen-specific Treg cells in immunological tolerance: implications for allergic diseases.
Azza Abdel-Gadir, Amir H Massoud, Talal A Chatila. F1000Res 2018
17
100

Engineering CAR-T cells.
Cheng Zhang, Jun Liu, Jiang F Zhong, Xi Zhang. Biomark Res 2017
183
100


Co-targeting of EGFR and autophagy signaling is an emerging treatment strategy in metastatic colorectal cancer.
Evangelos Koustas, Michalis V Karamouzis, Chrysovalantou Mihailidou, Dimitrios Schizas, Athanasios G Papavassiliou. Cancer Lett 2017
47
100


Immunotherapy for hepatocellular carcinoma: Current and future.
Michael P Johnston, Salim I Khakoo. World J Gastroenterol 2019
84
100


Oncolytic viral therapy for pancreatic cancer: current research and future directions.
Justin W Ady, Jacqueline Heffner, Elizabeth Klein, Yuman Fong. Oncolytic Virother 2014
10
100

Challenges and Opportunities for Pancreatic Cancer Immunotherapy.
Adham S Bear, Robert H Vonderheide, Mark H O'Hara. Cancer Cell 2020
81
100

Current Therapeutic Strategies in BRAF-Mutant Metastatic Colorectal Cancer.
Elisa Grassi, Jody Corbelli, Giorgio Papiani, Maria Aurelia Barbera, Federica Gazzaneo, Stefano Tamberi. Front Oncol 2021
4
100

Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial.
Masatoshi Kudo, Richard S Finn, Shukui Qin, Kwang-Hyub Han, Kenji Ikeda, Fabio Piscaglia, Ari Baron, Joong-Won Park, Guohong Han, Jacek Jassem,[...]. Lancet 2018
100

The Potential of CAR T Cell Therapy in Pancreatic Cancer.
Mehmet Akce, Mohammad Y Zaidi, Edmund K Waller, Bassel F El-Rayes, Gregory B Lesinski. Front Immunol 2018
57
100

Elucidating the link between collagen and pancreatic cancer: what's next?
Shin Hamada, Atsushi Masamune. Expert Rev Gastroenterol Hepatol 2018
8
100

Gastrin Vaccine Alone and in Combination With an Immune Checkpoint Antibody Inhibits Growth and Metastases of Gastric Cancer.
Jill P Smith, Hong Cao, Wenqiang Chen, Kanwal Mahmood, Teresa Phillips, Lynda Sutton, Allen Cato. Front Oncol 2021
2
100

Oral mTOR inhibitor everolimus in patients with gemcitabine-refractory metastatic pancreatic cancer.
Brian M Wolpin, Aram F Hezel, Thomas Abrams, Lawrence S Blaszkowsky, Jeffrey A Meyerhardt, Jennifer A Chan, Peter C Enzinger, Brittany Allen, Jeffrey W Clark, David P Ryan,[...]. J Clin Oncol 2009
230
100

Oncolytic immunotherapy: unlocking the potential of viruses to help target cancer.
Omid Hamid, Brianna Hoffner, Eduard Gasal, Jenny Hong, Richard D Carvajal. Cancer Immunol Immunother 2017
39
100

Potential targets for pancreatic cancer immunotherapeutics.
Lindzy F Dodson, William G Hawkins, Peter Goedegebuure. Immunotherapy 2011
50
100

Cancer statistics, 2018.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2018
100

TIM3 comes of age as an inhibitory receptor.
Yochai Wolf, Ana C Anderson, Vijay K Kuchroo. Nat Rev Immunol 2020
240
100

Current immunotherapy in gastrointestinal malignancies A Review.
Dushyant Singh Dahiya, Asim Kichloo, Jagmeet Singh, Michael Albosta, Manidhar Lekkala. J Investig Med 2021
4
100

IDO Expression in Cancer: Different Compartment, Different Functionality?
Annabel Meireson, Michael Devos, Lieve Brochez. Front Immunol 2020
41
100

Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape.
Xianjie Jiang, Jie Wang, Xiangying Deng, Fang Xiong, Junshang Ge, Bo Xiang, Xu Wu, Jian Ma, Ming Zhou, Xiaoling Li,[...]. Mol Cancer 2019
395
100

Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced, Unresectable Melanoma.
Jason Chesney, Igor Puzanov, Frances Collichio, Parminder Singh, Mohammed M Milhem, John Glaspy, Omid Hamid, Merrick Ross, Philip Friedlander, Claus Garbe,[...]. J Clin Oncol 2018
329
100

The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer.
Yelena Y Janjigian, Akihito Kawazoe, Patricio Yañez, Ning Li, Sara Lonardi, Oleksii Kolesnik, Olga Barajas, Yuxian Bai, Lin Shen, Yong Tang,[...]. Nature 2021
32
100


Cancer immunotherapy comes of age.
Ira Mellman, George Coukos, Glenn Dranoff. Nature 2011
100

CAR-T Cell Therapy-An Overview of Targets in Gastric Cancer.
Dominika Bębnowska, Ewelina Grywalska, Paulina Niedźwiedzka-Rystwej, Barbara Sosnowska-Pasiarska, Jolanta Smok-Kalwat, Marcin Pasiarski, Stanisław Góźdź, Jacek Roliński, Wojciech Polkowski. J Clin Med 2020
19
100

Combination chemotherapy and ALVAC-CEA/B7.1 vaccine in patients with metastatic colorectal cancer.
Howard L Kaufman, Heinz-Josef Lenz, John Marshall, Deepti Singh, Chris Garett, Christine Cripps, Malcolm Moore, Margaret von Mehren, Richard Dalfen, William J Heim,[...]. Clin Cancer Res 2008
70
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.